Related Experiment Video

Updated: Aug 18, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

The place of surgery in the treatment of re-emerging pulmonary tuberculosis

D Weissberg¹, Y Refaely

¹Department of Thoracic Surgery, Tel Aviv University Sackler School of Medicine, Tel Aviv, and E. Wolfson Medical Center, Holon, Israel. dovw@ccsg.tau.ac.il

Annali Italiani Di Chirurgia

|May 12, 2001

Abstract

Background:

A marked worldwide increase in prevalence of pulmonary tuberculosis occurred during the past 15 years. The reasons for this change include the worldwide epidemic of AIDS, poverty and unprecedented migration of people.

Methods:

During the past 12 years, we operated on 57 patients with pulmonary tuberculosis or its sequelae. In 42 patients the disease was active at the time of operation.

Results:

Two patients died of operative complications; one, of unrelated causes. There were three major non-fatal complications. In 49 patients tuberculosis was eradicated; five patients still have active disease and remain under drug therapy.

Conclusions:

High level of clinical awareness is the most important factor in disclosure and early treatment of pulmonary tuberculosis. Indications for operation are strengthened by alcoholism, drug abuse, poverty and other social factors. BCG vaccination of tuberculin-negative children should be considered as a preventive measure.

More Related Videos

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

Related Concept Videos

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Pneumothorax-II

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:

Articles linked to this work by shared authors, journal, and citation graph.

Biologic lung volume reduction therapy for advanced homogeneous emphysema.

The European respiratory journal·2009

Malignant thymoma invading pulmonary artery. Changing treatment options.

Annali italiani di chirurgia·2002

Diaphragm plication following phrenic nerve injury: a comparison of paediatric and adult patients.

Thorax·2002

Hyperthermic pleural perfusion with cisplatin: early clinical experience.

Cancer·2001

Late complications of collapse therapy for pulmonary tuberculosis.

Chest·2001

Resection and perfusion thermochemotherapy: a new approach for the treatment of thymic malignancies with pleural spread.

The Annals of thoracic surgery·2001

See all related articles